Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
AksharChem (India) Limited (AKSHARCHEM.NS)
Mehsana, IN
AksharChem (India) Limited is an Indian enterprise primarily engaged in the production and sale of dyes and pigments. Their product catalog features an array of dye intermediates, specifically H-acid, vinyl sulphone, ortho anicidine vinyl sulphone, and sulpho para vinyl sulphone. Additionally, they manufacture reactive dyes, including blue 21 and black 5, along with pigments like green 7 and violet 23, and precipitated silica. These materials are supplied to a diverse clientele spanning the textile, printing ink, plastic, paint, leather, and tire manufacturing sectors. Beyond its domestic operations, AksharChem (India) Limited exports its products globally to regions such as Europe, the Far East, Southeast Asia, China, and the United States. Founded in 1989, the company was formerly known as Audichem (India) Limited before officially changing its name to AksharChem (India) Limited in March 2003. Its corporate headquarters are situated in Mehsana, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.33% | -13.88% | -1.38% | +21.42% | -16.99% | -14.12% | -18.33% | -14.31% | -42.05% | -71.60% | -71.60% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%+7.6% ★ Q1'26: +16.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-109.3% Q1'26: +248.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-5.2% Q1'26: -4.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+0.1% Q1'26: +1.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+0.1% Q1'26: +0.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.7% ★ Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×6.38× Q1'26: 5.11× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
|---|---|---|---|---|
| Revenue |
2.60B
est: 2.60B (0.0%)
|
2.64B
est: 2.61B (+1.1%)
|
3.19B
est: 3.18B (+0.4%)
|
2.56B
est: 3.54B (-27.7%)
|
| EBITDA |
865.35M
est: 162.36M (+433.0%)
|
486.53M
est: 163.43M (+197.7%)
|
392.65M
est: 198.88M (+97.4%)
|
264.98M
est: 221.13M (+19.8%)
|
| EBIT |
806.97M
est: 65.63M (+1,129.6%)
|
436.28M
est: 66.06M (+560.4%)
|
337.52M
est: 80.39M (+319.9%)
|
197.70M
est: 89.39M (+121.2%)
|
| Net Income |
519.19M
est: 570.20M (-8.9%)
|
306.17M
est: 322.85M (-5.2%)
|
225.90M
est: 233.70M (-3.3%)
|
157.23M
est: 242.54M (-35.2%)
|
| SGA |
71.63M
est: 104.70M (-31.6%)
|
86.69M
est: 105.39M (-17.7%)
|
119.94M
est: 128.24M (-6.5%)
|
106.74M
est: 142.60M (-25.1%)
|
| EPS |
72.36
est: 71.00 (+1.9%)
|
37.33
est: 40.20 (-7.1%)
|
27.54
est: 29.10 (-5.4%)
|
19.17
est: 30.20 (-36.5%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-10 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-09 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-03 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-02 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-06-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ashok Dolatsinh Barot | Executive Director | 2M | male |
| Mehul Chandulal Naliyadhara | Company Secretary & Chief Compliance Officer | 926.0K | male |
| Amit D. Soni | Chief Financial Officer | 607.0K | male |
| Dakshesh N. Patel | General Manager of Marketing | — | male |
| Maheshkumar D. Patel | Vice President of Operations & Project | — | male |
| Bincy Mathew | General Manager of Corporate HR Admin | — | female |
| Munjal Mrugesh Jaykrishna | Joint MD, Chief Executive Officer & Executive Director | — | male |
| Paru Mrugesh Jaykrishna | Founder, Executive Chairperson & MD | — | female |
| Sachin Munjal Jaykrishna | President of Silica Dahej Unit & Whole Time Executive Director | — | male |
| Sunil Vaman Rane | General Manager of Accounts | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AKSHARCHEM.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
